vs

Side-by-side financial comparison of BayCom Corp (BCML) and MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Click either name above to swap in a different company.

MARAVAI LIFESCIENCES HOLDINGS, INC. is the larger business by last-quarter revenue ($49.9M vs $25.9M, roughly 1.9× BayCom Corp). BayCom Corp runs the higher net margin — 26.5% vs -71.6%, a 98.0% gap on every dollar of revenue. On growth, BayCom Corp posted the faster year-over-year revenue change (9.4% vs -11.8%). BayCom Corp produced more free cash flow last quarter ($30.1M vs $-24.9M). Over the past eight quarters, BayCom Corp's revenue compounded faster (2.9% CAGR vs -11.9%).

BayCom Corp is a U.S.-headquartered bank holding company operating through its wholly owned subsidiary Bay Commercial Bank. It primarily serves small and medium-sized enterprises and retail customers across Northern California, offering commercial lending, deposit products, personal banking services, and localized wealth management solutions.

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

BCML vs MRVI — Head-to-Head

Bigger by revenue
MRVI
MRVI
1.9× larger
MRVI
$49.9M
$25.9M
BCML
Growing faster (revenue YoY)
BCML
BCML
+21.3% gap
BCML
9.4%
-11.8%
MRVI
Higher net margin
BCML
BCML
98.0% more per $
BCML
26.5%
-71.6%
MRVI
More free cash flow
BCML
BCML
$55.0M more FCF
BCML
$30.1M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
BCML
BCML
Annualised
BCML
2.9%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCML
BCML
MRVI
MRVI
Revenue
$25.9M
$49.9M
Net Profit
$6.9M
$-35.7M
Gross Margin
25.8%
Operating Margin
36.6%
-117.9%
Net Margin
26.5%
-71.6%
Revenue YoY
9.4%
-11.8%
Net Profit YoY
12.1%
-37.7%
EPS (diluted)
$0.63
$-0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCML
BCML
MRVI
MRVI
Q4 25
$25.9M
$49.9M
Q3 25
$25.7M
$41.6M
Q2 25
$24.7M
$47.4M
Q1 25
$24.3M
$46.9M
Q4 24
$23.7M
$56.6M
Q3 24
$25.6M
$69.0M
Q2 24
$23.8M
$69.4M
Q1 24
$24.5M
$64.2M
Net Profit
BCML
BCML
MRVI
MRVI
Q4 25
$6.9M
$-35.7M
Q3 25
$5.0M
$-25.6M
Q2 25
$6.4M
$-39.6M
Q1 25
$5.7M
$-29.9M
Q4 24
$6.1M
$-25.9M
Q3 24
$6.0M
$-97.1M
Q2 24
$5.6M
$-9.8M
Q1 24
$5.9M
$-12.1M
Gross Margin
BCML
BCML
MRVI
MRVI
Q4 25
25.8%
Q3 25
13.6%
Q2 25
16.4%
Q1 25
16.5%
Q4 24
34.3%
Q3 24
46.7%
Q2 24
44.4%
Q1 24
40.3%
Operating Margin
BCML
BCML
MRVI
MRVI
Q4 25
36.6%
-117.9%
Q3 25
26.3%
-98.6%
Q2 25
35.3%
-139.8%
Q1 25
31.6%
-104.9%
Q4 24
34.2%
-66.7%
Q3 24
32.4%
-239.9%
Q2 24
31.9%
-19.4%
Q1 24
33.3%
-29.4%
Net Margin
BCML
BCML
MRVI
MRVI
Q4 25
26.5%
-71.6%
Q3 25
19.5%
-61.4%
Q2 25
25.8%
-83.5%
Q1 25
23.4%
-63.9%
Q4 24
25.9%
-45.8%
Q3 24
23.5%
-140.6%
Q2 24
23.6%
-14.1%
Q1 24
24.0%
-18.8%
EPS (diluted)
BCML
BCML
MRVI
MRVI
Q4 25
$0.63
$-0.24
Q3 25
$0.46
$-0.18
Q2 25
$0.58
$-0.27
Q1 25
$0.51
$-0.21
Q4 24
$0.55
$-0.21
Q3 24
$0.54
$-0.68
Q2 24
$0.50
$-0.07
Q1 24
$0.51
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCML
BCML
MRVI
MRVI
Cash + ST InvestmentsLiquidity on hand
$216.9M
Total DebtLower is stronger
$291.8M
Stockholders' EquityBook value
$338.6M
$212.4M
Total Assets
$2.6B
$770.6M
Debt / EquityLower = less leverage
1.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCML
BCML
MRVI
MRVI
Q4 25
$216.9M
Q3 25
$243.6M
Q2 25
$269.9M
Q1 25
$285.1M
Q4 24
$322.4M
Q3 24
$578.2M
Q2 24
$573.2M
Q1 24
$561.7M
Total Debt
BCML
BCML
MRVI
MRVI
Q4 25
$291.8M
Q3 25
$292.8M
Q2 25
$293.9M
Q1 25
$294.9M
Q4 24
$295.9M
Q3 24
$521.7M
Q2 24
$522.5M
Q1 24
$523.3M
Stockholders' Equity
BCML
BCML
MRVI
MRVI
Q4 25
$338.6M
$212.4M
Q3 25
$334.3M
$245.4M
Q2 25
$330.6M
$265.9M
Q1 25
$329.3M
$300.6M
Q4 24
$324.4M
$325.3M
Q3 24
$321.7M
$344.9M
Q2 24
$315.3M
$434.7M
Q1 24
$314.2M
$410.7M
Total Assets
BCML
BCML
MRVI
MRVI
Q4 25
$2.6B
$770.6M
Q3 25
$2.6B
$849.2M
Q2 25
$2.6B
$897.0M
Q1 25
$2.6B
$959.8M
Q4 24
$2.7B
$1.0B
Q3 24
$2.6B
$1.3B
Q2 24
$2.6B
$1.4B
Q1 24
$2.6B
$1.4B
Debt / Equity
BCML
BCML
MRVI
MRVI
Q4 25
1.37×
Q3 25
1.19×
Q2 25
1.11×
Q1 25
0.98×
Q4 24
0.91×
Q3 24
1.51×
Q2 24
1.20×
Q1 24
1.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCML
BCML
MRVI
MRVI
Operating Cash FlowLast quarter
$31.8M
$-22.8M
Free Cash FlowOCF − Capex
$30.1M
$-24.9M
FCF MarginFCF / Revenue
116.2%
-49.9%
Capex IntensityCapex / Revenue
6.7%
4.2%
Cash ConversionOCF / Net Profit
4.64×
TTM Free Cash FlowTrailing 4 quarters
$51.1M
$-70.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCML
BCML
MRVI
MRVI
Q4 25
$31.8M
$-22.8M
Q3 25
$7.3M
$-15.2M
Q2 25
$6.4M
$-10.3M
Q1 25
$9.3M
$-9.4M
Q4 24
$30.4M
$-14.6M
Q3 24
$9.6M
$13.1M
Q2 24
$7.7M
$17.4M
Q1 24
$5.1M
$-8.5M
Free Cash Flow
BCML
BCML
MRVI
MRVI
Q4 25
$30.1M
$-24.9M
Q3 25
$6.2M
$-18.1M
Q2 25
$5.6M
$-13.1M
Q1 25
$9.1M
$-14.6M
Q4 24
$28.7M
$-20.5M
Q3 24
$9.4M
$4.5M
Q2 24
$7.4M
$7.9M
Q1 24
$3.9M
$-14.1M
FCF Margin
BCML
BCML
MRVI
MRVI
Q4 25
116.2%
-49.9%
Q3 25
24.3%
-43.4%
Q2 25
22.8%
-27.7%
Q1 25
37.6%
-31.2%
Q4 24
121.1%
-36.2%
Q3 24
36.6%
6.6%
Q2 24
31.2%
11.4%
Q1 24
16.1%
-22.0%
Capex Intensity
BCML
BCML
MRVI
MRVI
Q4 25
6.7%
4.2%
Q3 25
4.3%
7.0%
Q2 25
3.0%
6.1%
Q1 25
0.6%
11.2%
Q4 24
7.2%
10.3%
Q3 24
1.0%
12.4%
Q2 24
1.0%
13.8%
Q1 24
4.7%
8.8%
Cash Conversion
BCML
BCML
MRVI
MRVI
Q4 25
4.64×
Q3 25
1.47×
Q2 25
1.00×
Q1 25
1.63×
Q4 24
4.96×
Q3 24
1.60×
Q2 24
1.37×
Q1 24
0.86×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCML
BCML

Segment breakdown not available.

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

Related Comparisons